Drugs for Dystonia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 79)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Levodopa |
Approved |
Phase 4 |
|
59-92-7, 63-84-3 |
6047 |
Synonyms:
(-)-3-(3,4-Dihydroxyphenyl)-L-alanine
(−)-3-(3,4-DIHYDROXYPHENYL)-L-ALANINE
(-)-Dopa
(−)-DOPA
(+-)-3-(3,4-Dihydroxyphenyl)alanine
(+-)-Dopa
(+/-) 3-(3,4-dihydroxyphenyl)alanine
(2S)-2-Amino-3-(3,4-dihydroxyphenyl)propanoate
(2S)-2-Amino-3-(3,4-dihydroxyphenyl)propanoic acid
(R,S)-Dopa
2-amino-3-(3,4-Dihydroxyphenyl)propanoate
2-amino-3-(3,4-Dihydroxyphenyl)propanoic acid
3 Hydroxy DL tyrosine
3 Hydroxy L tyrosine
3-(3,4-Dihydroxyphenyl)-DL-alanine
3-(3,4-Dihydroxyphenyl)-L-alanine
3,4 Dihydroxyphenylalanine
3,4-Dihydroxy-DL-phenylalanine
3,4-Dihydroxy-L-phenylalanine
3,4-dihydroxy-L-phenylalanine|Inbrija® (levodopa inhalation powder)|L-DOPA|Sinemet®
3,4-Dihydroxyphenylalanine
3',4'-Dihydroxyphenylalanine
3,4-Dihydroxyphenyl-L-alanine
3-Hydroxy-DL-tyrosine
3-Hydroxy-L-tyrosine
3-Hydroxytyrosine
a-amino-3,4-Dihydroxy-benzenepropanoate
a-amino-3,4-Dihydroxy-benzenepropanoic acid
alpha-amino-3,4-Dihydroxy-benzenepropanoate
alpha-amino-3,4-Dihydroxy-benzenepropanoic acid
alpha-amino-Hydrocaffeic acid
b-(3,4-Dihydroxyphenyl)-a-alanine
b-(3,4-Dihydroxyphenyl)-a-L-alanine
b-(3,4-Dihydroxyphenyl)alanine
b-(3,4-Dihydroxyphenyl)-DL-a-alanine
b-(3,4-Dihydroxyphenyl)-L-alanine
Bendopa
beta Hydroxytyrosine
beta-(3,4-Dihydroxyphenyl)alanine
beta-(3,4-Dihydroxyphenyl)-alpha-alanine
beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine
beta-(3,4-Dihydroxyphenyl)-DL-alpha-alanine
beta-(3,4-Dihydroxyphenyl)-L-alanine
beta-Hydroxytyrosine
BROCADOPA
Cidandopa
Deadopa
Dihydroxy-L-phenylalanine
Dihydroxyphenylalanine
Dihydroxyphenylalanine hydrochloride, (2:1)
DL-3,4-Dihydroxyphenylalanine
DL-3',4'-Dihydroxyphenylalanine
DL-3,4-Dopa
DL-3-Hydroxytyrosine
DL-4,5-Dihydroxyphenylalanine
DL-b-(3,4-Dihydroxyphenyl)-a-alanine
DL-b-(3,4-Dihydroxyphenyl)alanine
DL-beta-(3,4-Dihydroxyphenyl)alanine
DL-beta-(3,4-Dihydroxyphenyl)-alpha-alanine
DL-Dihydroxyphenylalanine
DL-Dioxyphenylalanine
|
DL-Β-(3,4-dihydroxyphenyl)alanine
DL-Β-(3,4-dihydroxyphenyl)-α-alanine
Dopa
Dopaflex
Dopaidan
Dopal
Dopal-Fher
Dopalina
Dopar
Doparkine
Doparl
Dopasol
Dopaston
Dopastone
Dopastral
Dopicar
Doprin
Eldopal
Eldopar
Eldopatec
Eurodopa
Helfo-dopa
INBRIJA
Insulamina
L 3,4 Dihydroxyphenylalanine
L Dopa
L-(-)-Dopa
L-3-(3,4-Dihydroxyphenyl)-alanine
L-3,4-Dihydroxyphenylalanine
L-4-5-Dihydroxyphenylalanine
Laradopa
Larodopa
L-b-(3,4-Dihydroxyphenyl)-a-alanine
L-b-(3,4-Dihydroxyphenyl)alanine
L-beta-(3,4-Dihydroxyphenyl)alanine
L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine
L-Dihydroxyphenylalanine
L-DOPA
LDP540
Ledopa
Levedopa
Levodopa
Levodopum
Levopa
L-Β-(3,4-dihydroxyphenyl)alanine
Maipedopa
Medphano brand OF levodopa
NSC-118381
Parda
Pardopa
Prodopa
Roberts brand OF levodopa
Roche brand OF levodopa
SINEMET
Syndopa
V-1512
Veldopa
Weldopa
Β-(3,4-dihydroxyphenyl)alanine
Β-(3,4-dihydroxyphenyl)-DL-α-alanine
Β-(3,4-dihydroxyphenyl)-L-alanine
|
|
2 |
|
Dopamine |
Approved |
Phase 4 |
|
62-31-7, 51-61-6 |
681 |
Synonyms:
2-(3,4-Dihydroxyphenyl)ethylamine
3,4 Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenylethylamine
3-Hydroxytyramine
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-AZANYLETHYL)BENZENE-1,2-DIOL
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL-279
CARBILEV
Deoxyepinephrine
Dopamin
Dopamina
DOPAMINE
DOPAMINE HCL
|
Dopamine hydrochloride
DOPAMIN-NATTERMAN
Dopaminum
Dopastat
Dophamine
DOPMIN
Dynatra
Hydrochloride, dopamine
Hydroxytyramin
Hydroxytyramine
Intropin
Medopa
NSC-169105
NSC-173182
Oxytyramine
PARCOPA
Revivan
SABAX DOPAMIN
SELECTAJET
SINEMET
|
|
3 |
|
Risperidone |
Approved, Investigational |
Phase 4 |
|
106266-06-2 |
5073 |
Synonyms:
Belivon
Buspirone
Consta, risperdal
LY03004
LY-03004
N05AX08
Okedi®|R-64-766|R-64766|Risperdal®
PERSERIS KIT
R-64,766
R-64766
R-64-766
RCN3028
RCN-3028
Rispen
Risperdal
Risperdal consta
RISPERDAL CONSTA LONG ACTING
|
RISPERDAL M
Risperdal m-tab
RISPERDAL QUICKLET
RISPERDONE
Risperidal
Risperidal M-Tab
Risperidona
Risperidona [Spanish]
Risperidone
Rispéridone
Risperidonum
Risperidonum [Latin]
Risperin
Rispolept
Rispolin
Sequinan
Spiron
|
|
4 |
|
Olanzapine |
Approved, Investigational |
Phase 4 |
|
132539-06-1 |
135398745 4585 |
Synonyms:
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine
2-METHYL-4-(4-METHYL-1-PIPERAZINYL)-10H-THIENO[2,3-B][1,5]BENZODIAZEPINE
ARKOLAMYL
Lanzac
LY170053
LY-170053
LY-170053|Zyprexa®
Olansek
OLANZAPIN
Olanzapina
|
OLANZAPINE
Olanzapine pamoate
Olanzapinum
Symbyax
ZALASTA
Zolafren
Zydis
Zyprexa
Zyprexa intramuscular
Zyprexa zydis
|
|
5 |
|
Amantadine |
Approved |
Phase 4 |
|
768-94-5 |
2130 |
Synonyms:
1 Aminoadamantane
1-Adamantanamine
1-Adamantylamine
1-Aminoadamantane
AbZ brand OF amantadine hydrochloride
Adamantamine
Adamantanamine
Adamantylamine
Adekin
ADS-5102|Gocovri®|Symadine®|Symmetrel®
AL, amantadin
Aliud brand OF amantadine sulfate
Alliance brand OF amantadine hydrochloride
Aman
Amanta
Amanta hci azu
Amanta sulfate azu
Amantadin al
Amantadin azu
Amantadin neuraxpharm
Amantadin ratiopharm
Amantadin stada
Amantadina
Amantadina juventus
Amantadina llorente
AMANTADINE
Amantadine base
Amantadine HCL
Amantadine hydrochloride
Amantadine sulfate
Amantadinneuraxpharm
Amantadin-neuraxpharm
Amantadinratiopharm
Amantadin-ratiopharm
Amantadinum
Amanta-hci-azu
AmantaHCIAZU
Amantasulfateazu
Amanta-sulfate-azu
Amantidine
Aminoadamantane
Amixx
AZU, amantadin
Azupharma brand OF amantadine hydrochloride
Azupharma brand OF amantadine sulfate
Cerebramed
Ciba geigy brand OF amantadine hydrochloride
Ciba-geigy brand OF amantadine hydrochloride
Desitin brand OF amantadine hydrochloride
Du pont brand OF amantadine hydrochloride
|
Endantadine
endo Brand OF amantadine hydrochloride
Gen amantadine
Gen-amantadine
GenAmantadine
Genpharm brand OF amantadine hydrochloride
Hexal brand OF amantadine sulfate
Hormosan brand OF amantadine sulfate
Hydrochloride, amantadine
Infecto flu
Infecto-flu
InfectoFlu
Infectopharm brand OF amantadine hydrochloride
Infex
Juventus brand OF amantadine hydrochloride
Juventus, amantadina
Krewel brand OF amantadine hydrochloride
Llorente brand OF amantadine hydrochloride
Llorente, amantadina
Mantadine
Mantadix
Merz brand OF amantadine sulfate
Midantan
Neuraxpharm brand OF amantadine sulfate
Neuro hexal brand OF amantadine sulfate
Novartis brand OF amantadine hydrochloride
NSC-341865
Orion brand OF amantadine hydrochloride
Pharmascience brand OF amantadine hydrochloride
Pk-Merz
PMS Amantadine
PMSAmantadine
PMS-Amantadine
Ratiopharm brand OF amantadine hydrochloride
Solvay brand OF amantadine hydrochloride
Stada brand OF amantadine hydrochloride
Stada brand OF amantadine sulfate
Stada, amantadin
Sulfate, amantadine
Symadine
Symmetrel
TCMDC-125869
Thiemann brand OF amantadine hydrochloride
Tregor
Tricyclo[3.3.1.1(3,7)]decan-1-amine
Tricyclo[3.3.1.1(3,7)]decan-1-ylamine
Tricyclo[3.3.1.1(3,7)]decane-1-amine
Viregyt
Virosol
Wiregyt
|
|
6 |
|
Acetylcholine |
Approved, Investigational |
Phase 4 |
|
51-84-3 |
187 |
Synonyms:
[2-(ACETYLOXY)ETHYL]TRIMETHYLAZANIUM
2-(Acetyloxy)-N,N,N-trimethylethanaminium
2-ACETOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AZANIUM
Acetilcolina cusi
Acetyl choline ion
Acetylcholine
Acetylcholine bromide
Acetylcholine cation
Acetylcholine chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
ACETYLCHOLINE, ACH
Acetylcholinium: acetyl-choline
|
ACh
ACh|E1001|O-acetylcholine
Alcon brand OF acetylcholine chloride
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
E1001
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
7 |
|
Carbidopa, levodopa drug combination |
|
Phase 4 |
|
|
|
8 |
|
Antiparkinson Agents |
|
Phase 4 |
|
|
|
9 |
|
incobotulinumtoxinA |
|
Phase 4 |
|
|
|
Synonyms:
|
10 |
|
Psychotropic Drugs |
|
Phase 4 |
|
|
|
11 |
|
Analgesics, Non-Narcotic |
|
Phase 4 |
|
|
|
12 |
|
Analgesics |
|
Phase 4 |
|
|
|
13 |
|
rimabotulinumtoxinB |
|
Phase 4 |
|
|
|
14 |
|
Dopamine Antagonists |
|
Phase 4 |
|
|
|
15 |
|
Dopamine Agents |
|
Phase 4 |
|
|
|
16 |
|
Antipsychotic Agents |
|
Phase 4 |
|
|
|
17 |
|
Antiemetics |
|
Phase 4 |
|
|
|
18 |
|
Serotonin Uptake Inhibitors |
|
Phase 4 |
|
|
|
19 |
|
Gastrointestinal Agents |
|
Phase 4 |
|
|
|
20 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
21 |
|
Antiviral Agents |
|
Phase 4 |
|
|
|
22 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
23 |
|
Anticonvulsants |
|
Phase 4 |
|
|
|
24 |
|
Bromides |
|
Phase 4 |
|
|
|
25 |
|
Pyridostigmine Bromide |
|
Phase 4 |
|
101-26-8 |
|
Synonyms:
KALYMIN
MESTINON
MESTINON 10
MESTINON RET
NSC-679759
|
PYRIDOSTIGMINE BROMIDE
REGONAL
REGONOL
RO-1-5130
|
|
26 |
|
Cholinesterase Inhibitors |
|
Phase 4 |
|
|
|
27 |
|
Cholinergic Agents |
|
Phase 4 |
|
|
|
28 |
|
Botulinum Toxins |
|
Phase 4 |
|
|
|
29 |
|
abobotulinumtoxinA |
|
Phase 4 |
|
|
|
Synonyms:
ABOBOTULINUMTOXINA
BONT/A
BONTOXILYSIN A
BOTOX
BOTULINUM TOXIN TYPE A
|
BOTULINUM TOXINS, TYPE A
BOTULOTOXIN A
BTX-A
ONABOTULINUMTOXINA
|
|
30 |
|
Botulinum Toxins, Type A |
|
Phase 4 |
|
|
|
31 |
|
Serotonin |
Investigational, Nutraceutical |
Phase 4 |
|
50-67-9 |
5202 |
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5 Hydroxytryptamine
5-HT
5-HT|serotonin
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
5-Hydroxy-tryptamine
|
Antemovis
DS Substance
Enteramin
Enteramine
Hippophaine
Hydroxytryptamine
SEROTONIN
Serotonine
sérotonine
Thrombocytin
Thrombotonin
|
|
32 |
|
Zonisamide |
Approved, Investigational |
Phase 3 |
|
68291-97-4 |
5734 |
Synonyms:
1,2-Benzisoxazole-3-methanesulfonamide
1,2-Benzisoxazole-3-methanesulphonamide
3 Sulfamoylmethyl 1,2 benzisoxazole
3-(Sulfamoylmethyl)-1,2-benzisoxazole
3-(Sulphamoylmethyl)-1,2-benzisoxazole
3-Sulfamoylmethyl-1,2-benzisoxazole
AD-810
AD-810|CI-912|PD-110843|Zonegran®
Benzo[D]isoxazol-3-yl-methanesulfonamide
Benzo[D]isoxazol-3-yl-methanesulphonamide
CI-912
Elan brand OF zonisamide
|
Exceglan
Excegram
Excegran
PD-110843
Zonegran
Zonisamida
Zonisamida [Spanish]
Zonisamide
Zonisamide monosodium
Zonisamidum
Zonisamidum [Latin]
|
|
33 |
|
Hormones |
|
Phase 3 |
|
|
|
34 |
|
Pharmaceutical Solutions |
|
Phase 3 |
|
|
|
35 |
|
Calcium, Dietary |
|
Phase 3 |
|
|
|
36 |
|
calcium channel blockers |
|
Phase 3 |
|
|
|
37 |
|
Calcium |
Nutraceutical |
Phase 3 |
|
7440-70-2 |
271 |
Synonyms:
Ca
Ca(2+)
Ca2+
Calcio
CALCIUM
Calcium element
|
CALCIUM ion
Calcium(2+)
Calcium, doubly charged positive ion
Calcium, elemental
Elemental calcium
Kalzium
|
|
38 |
|
Dronabinol |
Approved, Illicit |
Phase 2 |
|
1972-08-3 |
16078 |
Synonyms:
&Delta
Δ<sup>9</sup>-THC|Abbott 40566|delta9-THC|Marinol®|tetrahydrocannabinol|THC
(-)- delta 9-Tetrahydrocannabinol
(-)-3,4-trans-delta1-Tetrahydrocannabinol
(-)-3,4-trans-Δ1-Tetrahydrocannabinol
(-)-delta 1-Tetrahydrocannabinol
(-)-delta 9-THC
(-)-delta 9-trans-Tetrahydrocannabinol
(-)-delta1-Tetrahydrocannabinol
(-)-delta9-Tetrahydrocannabinol
(-)-delta9-THC
(-)-delta9-trans-Tetrahydrocannabinol
(-)-trans-delta 1-Tetrahydrocannabinol
(-)-trans-delta 9-Tetrahydrocannabinol
(-)-trans-delta 9-THC
(-)-trans-delta1-Tetrahydrocannabinol
(-)-trans-delta9-Tetrahydrocannabinol
(-)-trans-delta9-THC
(-)-trans-Δ1-Tetrahydrocannabinol
(-)-trans-Δ9-Tetrahydrocannabinol
(-)-trans-Δ9-THC
(-)-Δ1-Tetrahydrocannabinol
(-)-Δ9-Tetrahydrocannabinol
(-)-Δ9-THC
(-)-Δ9-trans-tetrahydrocannabinol
(L)-delta 1-Tetrahydrocannabinol
(l)-delta1-Tetrahydrocannabinol
(l)-Δ1-Tetrahydrocannabinol
14C-delta 1-Tetrahydrocannabinol
1-trans-delta 9-Tetrahydrocannabinol
1-trans-delta-9-Tetrahydrocannabinol
1-trans-Δ-9-tetrahydrocannabinol
3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,D)pyran-1-ol
6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol
6H-DIBENZO(B,D)PYRAN-1-OL, 6A,7,8,10A-TETRAHYDRO-6,6,9-TRIMETHYL-3-PENTYL-, (6AR,10AR)-
9 Ene tetrahydrocannabinol
9-Ene-tetrahydrocannabinol
9-tetrahydrocannabinol
9-THC
ABBOTT 40566
ABBOTT-40566
Dea No. 7369
Dea No. 7370
delta 1-Tetrahydrocannabinol
delta 1-THC
delta 9-Tetrahydrocannabinol
delta 9-THC
delta 9-trans-Tetrahydrocannabinol
Delta(1)-Tetrahydrocannabinol
delta(1)-THC
delta(9)-Tetrahydrocannabinol
Delta(9)-THC
delta1-Tetrahydrocannabinol
|
delta1-THC
delta9-Tetrahydrocannabinol
DELTA-9-TETRAHYDROCANNABINOL
delta9-THC
DELTA-9-THC
delta9-trans-Tetrahydrocannabinol
Deltanyne
Dronabinol
Dronabinol [Usan:Inn]
DRONABINOLEN
Dronabinolum
Dronabinolum [Latin]
Exocyclic delta (9)(11)-tetrahydrocannabiol
J882F
L-delta 1-trans-Tetrahydrocannabinol
l-delta1-trans-Tetrahydrocannabinol
L-trans-delta 9-Tetrahydrocannabinol
l-trans-delta9-Tetrahydrocannabinol
l-trans-Δ9-Tetrahydrocannabinol
l-Δ1-trans-Tetrahydrocannabinol
Marinol
NSC-134454
Primolut
QCD 84924
QCD-84924
Solvay brand OF tetrahydrocannabinol
SP 104
SP-104
Syndros
Tetrahydrocannabinol
Tetrahydrocannabinol, (6ar-cis)-isomer
Tetrahydrocannabinol, (6as-cis)-isomer
Tetrahydrocannabinol, (6a-trans)-isomer
Tetrahydrocannabinol, trans isomer
Tetrahydrocannabinol, trans-(+-)-isomer
Tetrahydrocannabinol, trans-isomer
THC
trans-(-)-delta9-Tetrahydrocannabinol
trans-(-)-Δ9-Tetrahydrocannabinol
trans-delta (-)-9-Tetrahydrocannabinol
trans-delta 9-Tetrahydrocannabinol
trans-delta9-Tetrahydrocannabinol
trans-Δ9-Tetrahydrocannabinol
Δ(1)-tetrahydrocannabinol
Δ(9)-THC
Δ1-Tetrahydrocannabinol
Δ1-THC
Δ9-tetrahydrocannabinol
Δ-9-tetrahydrocannabinol
Δ9-THC
Δ-9-THC
Δ9-trans-Tetrahydrocannabinol
|
|
39 |
|
Trihexyphenidyl |
Approved |
Phase 2 |
|
144-11-6 |
5572 |
Synonyms:
(RS)-1-CYCLOHEXYL-1-PHENYL-3-(1-PIPERIDYL)PROPAN-1-OL
AHP brand OF trihexyphenidyl hydrochloride
apo Trihex
Apotex brand OF trihexyphenidyl hydrochloride
Apo-trihex
ApoTrihex
Artane
Artane®|benzhexol
Aventis brand OF trihexyphenidyl hydrochloride
Benzhexol
BENZHEXOL HYDROCHLORIDE
Cyclodol
CYCLODOLE
Cypress brand OF trihexyphenidyl hydrochloride
Eisai brand OF trihexyphenidyl hydrochloride
Hexal brand OF trihexyphenidyl hydrochloride
Hipokinon
Lederle brand OF trihexyphenidyl hydrochloride
Liquipharm brand OF trihexyphenidyl hydrochloride
NSC-12268
Parkinane
|
Parkopan
Pharmaceutical associates brand OF trihexyphenidyl hydrochloride
Psicofarma brand OF trihexyphenidyl hydrochloride
Rugby brand OF trihexyphenidyl hydrochloride
Schrein brand OF trihexyphenidyl hydrochloride
Trihexane
Trihexidyl hydrochloride
TRIHEXIFENIDILO
Trihexylphenidyl
Trihexylphenidyle
Trihexylphenizyl
TRIHEXYPHENIDYL
Trihexyphenidyl hydrochloride
Trihexyphenidyl hydrochloride elixir
Trihexyphenidyl wyeth brand
Trihexyphenidyle
TRIHEXYPHÉNIDYLE
TRIHEXYPHENIDYLUM
Triphenidyl
Wyeth brand OF trihexyphenidyl
Wyeth brand OF trihexyphenidyl hydrochloride
|
|
40 |
|
Mexiletine |
Approved, Investigational |
Phase 2 |
|
5370-01-4, 31828-71-4 |
4178 |
Synonyms:
(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine
(±)-1-(2,6-dimethylphenoxy)propan-2-amine
(2Rs)-1-(2,6-Dimethylphenoxy)-2-aminopropane
1-(2',6'-Dimethylphenoxy)-2-aminopropane
1-(2,6-Dimethylphenoxy)-2-propanamine
1-Methyl-2-(2,6-xylyloxy)ethanamine
Boehringer ingelheim brand OF mexiletine hydrochloride
KO-1173
KO-1173 CL
KO-1173-CL
Mexiletene
Mexiletina
Mexiletina [INN-Spanish]
Mexiletine
|
Mexilétine
MEXILETINE HCL
Mexiletine hydrochloride
Mexiletinum
Mexiletinum [INN-Latin]
Mexilitine
Mexitil
MEXITIL P.L.
Mexitil PL
Mexitil®
Mexityl
Novo mexiletine
Novo-mexiletine
Novopharm brand OF mexiletine hydrochloride
|
|
41 |
|
Amlodipine |
Approved |
Phase 2 |
|
88150-42-9 |
2162 |
Synonyms:
(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-Ethyl 5-methylester, (±)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid
Almirall brand OF amlodipine besilate
Amlocard
Amlodipine
Amlodipine Benzenesulfonate
Amlodipine besilate
Amlodipine besylate
amlodipine besylate|amlodipine maleate|Copalia® (amlodipine + valsartan)|Katerzia® (amlodipine oral suspension, 1 mg/mL)|Norvasc®|UK-4834011
Amlodipine free base
Amlodipine maleate
Amlodipine maleate (1:1)
Amlodipine, (+-)-isomer
Amlodipine, (+-)-isomer, maleate (1:1)
Amlodipine, (R)-isomer
Amlodipine, (S)-isomer, maleate (1:1)
Amlodipino
Amlodipino [Spanish]
Amlodipinum
|
Amlodipinum [Latin]
Amlodis
Amlor
AMVAZ
Astudal
ASTUDAL 5
CKD-330 COMPONENT AMLODIPINE
Coroval
Eczacibasi brand OF amlodipine besilate
HGP0904
HGP-0904
Istin
Lipinox
Lotrel
Mack brand OF amlodipine besilate
NORVAS
Norvasc
Pelmec
Pfizer brand OF amlodipine besilate
Racemic amlodipine
|
|
42 |
|
Diphenhydramine |
Approved, Investigational |
Phase 2 |
|
147-24-0, 58-73-1 |
3100 |
Synonyms:
[2-(DIPHENYLMETHOXY)ETHYL]DIMETHYLAMINE
2-(Benzhydryloxy)-N,N-dimethylethylamine
2-Diphenylmethoxy-N,N-demthylethanamine
2-Diphenylmethoxy-N,N-dimethylethylamine
a-(2-Dimethylaminoethoxy)diphenylmethane
Alledryl
Allerdryl
Allergan
Allergina
alpha-(2-Dimethylaminoethoxy)diphenylmethane
ANTITUSSIVE
b-Dimethylaminoethanol diphenylmethyl ether
b-Dimethylaminoethyl benzhydryl ether
BELDIN
BELIX
Benadryl
BENADRYL PRESERVATIVE FREE
Benadryl®|benzhydramine|dimehydrinate
Bendylate
Benhydramin
Benylin
Benzantin
Benzhydramine
beta-Dimethylaminoethanol diphenylmethyl ether
beta-Dimethylaminoethyl benzhydryl ether
CALADRYL
Citrate, diphenhydramine
COLTEX
DIBENIL
Difenhidramina
Difenhydramine
Dimedrol
Dimedrolum
DIMEHYDRINATE
Dimethylamine benzhydryl ester
Diphamine
Diphantine
|
DIPHEN
DIPHENHYDRAMINE
Diphenhydramine citrate
Diphenhydramine citrate (1:1)
DIPHENHYDRAMINE HCL
Diphenhydramine hydrochloride
DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE
Diphenhydraminum
Diphenylhydramin
Diphenylhydramine
Dobacen
Dormin
DREEMON
DYTUSS
FEDRIL
GPPE COUGH EXPECT PAED
GPPE ORAL SOLN
HISTERGAN
HYDRAMINE
Hydrochloride, diphenhydramine
MEDINEX
N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine
NIGHTCALM
NSC-33299
NYTOL
NYTOL ONE-A-NIGHT
O-Benzhydryldimethylaminoethanol
PAXIDORM
Restamin
SILPHEN
SLEEPIA
SYNTEDRIL
TIXYLIX CATARRH
VICKS FORMULA 44
Α-(2-dimethylaminoethoxy)diphenylmethane
Β-dimethylaminoethanol diphenylmethyl ether
Β-dimethylaminoethyl benzhydryl ether
|
|
43 |
|
Promethazine |
Approved, Investigational |
Phase 2 |
|
60-87-7 |
4927 |
Synonyms:
(2-Dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine
10-(2-Dimethylaminopropyl)phenothiazine
10-[2-(Dimethylamino)propyl]phenothiazine
Atosil
Diphergan
Diprazin
Hydrochloride, promethazine
Isopromethazine
Lilly 1516
N-(2'-Dimethylamino-2'-methyl)ethylphenothiazine
N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,a-Trimethyl-10H-phenothiazine-10-ethanamine
N,N,Α-trimethyl-10H-phenothiazine-10-ethanamine
NSC-30321
Phenargan
Phenergan
Phenergan®|Sominex®
Phensedyl
Pipolfen
Pipolphen
Proazaimine
Proazamine
|
Promazinamide
Promet
Prometazin
Prometazina
Prometazine
PROMETHACON
Promethazin
PROMETHAZINE
Promethazine hydrochloride
Promethazinum
PROMETHEGAN
Promethiazine
Promezathine
Prothazin
Prothazine
Pyrethia
Remsed
RP-3277
Rumergan
SOMINEX
ZIPAN-25
ZIPAN-50
|
|
44 |
|
Levetiracetam |
Approved |
Phase 2 |
|
102767-28-2 |
441341 5284583 |
Synonyms:
AGB-101
alpha Ethyl 2 oxo 1 pyrrolidineacetamide
alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
DESITREND
e Keppra
ELEPSIA XR
Etiracetam
Etiracetam, R isomer
Etiracetam, R-isomer
Etiracetam, S isomer
Etiracetam, S-isomer
Keppra
KEPPRA XR
Keppra®|Spritam®|UCB L059|UCB-L 059
LEVETIRACETAM
Levetiracetam [INN]
LEVETIRACETAM IN SODIUM CHLORIDE
|
Levetiracetame
Levetiracetamum
Levetiracetamum [INN-Latin]
Levitiracetam
MATEVER
N03AX14
R-Isomer etiracetam
S-Isomer etiracetam
SPRITAM
UCB brand OF levetiracetam
Ucb L059
Ucb L060
UCB-22059
Ucb-L059
UcbL060
Ucb-L060
|
|
45 |
|
Hormone Antagonists |
|
Phase 2 |
|
|
|
46 |
|
Hallucinogens |
|
Phase 2 |
|
|
|
47 |
|
Muscarinic Antagonists |
|
Phase 2 |
|
|
|
48 |
|
Cholinergic Antagonists |
|
Phase 2 |
|
|
|
49 |
|
Anti-Arrhythmia Agents |
|
Phase 2 |
|
|
|
50 |
|
Sodium Channel Blockers |
|
Phase 2 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 291)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
The Impact of Botulinum Toxin Treatment in Quality of Life of Cervical Dystonia Patients |
Unknown status |
NCT01664013 |
Phase 4 |
Nuronox |
2 |
Dopamine Treatment in Children With Cerebral Palsy With Dystonia- A Double Blind Controlled Study |
Unknown status |
NCT01361373 |
Phase 4 |
L- DOPA;placebo |
3 |
Randomisierte, Doppelblinde Langzeitstudie Zur Klinischen Wirksamkeit Der Bilateralen Globus Pallidus Internus-Stimulation Bei Idiopathischer Generalisierter Oder Segmentaler Dystonie |
Unknown status |
NCT00142259 |
Phase 4 |
|
4 |
A Placebo Controlled, Cross-over, Double Blind, Randomized, Clinical Trial to Compare the Efficacy and Safety of Meditoxin® Injection for Cervical Dystonia in Adults With Cerebral Palsy |
Completed |
NCT01860196 |
Phase 4 |
Meditoxin;Normal saline |
5 |
An Open Label Safety and Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) Injectable Solution in Patients With Cervical Dystonia |
Completed |
NCT00702754 |
Phase 4 |
|
6 |
OnabotulinumtoxinA in the Management of Psychogenic Dystonia |
Completed |
NCT02618889 |
Phase 4 |
|
7 |
Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia |
Completed |
NCT00528541 |
Phase 4 |
|
8 |
Pre-injection, Multi-channel EMG Mapping to Optimize Botulinum Toxin Type A Efficacy in Cervical Dystonia. |
Completed |
NCT00773253 |
Phase 4 |
Botulinum toxin A |
9 |
Prospective, Single-arm, Multicenter Trial to Investigate the Efficacy and Safety of NT 201 and the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Patients With Cervical Dystonia |
Completed |
NCT00541905 |
Phase 4 |
NT 201 |
10 |
A Double Blind, Randomized, Multi-center, Cross-over Study to Demonstrate the Non-inferiority of Dysport® in Comparison With Botox®, Assuming a Bioequivalence Ratio of 2.5:1 Units, in the Cervical Dystonia |
Completed |
NCT00950664 |
Phase 4 |
Dysport® (abobotulinumtoxinA);Botox® (onabotulinumtoxinA) |
11 |
A Randomized Controlled Trial Study of Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism |
Completed |
NCT00331825 |
Phase 4 |
Risperidone and Olanzapine |
12 |
An Open Label Evaluation of MIDI to Quantify Performance Change in Subjects With Musician's Dystonia After Treatment With Botulinum Toxin Type B (Myobloc ®). |
Completed |
NCT00208091 |
Phase 4 |
Botulinum toxin, type B |
13 |
Pilot Study of the Effect of Botulinum Toxin Type A Treatment on Swallowing in Patients With Cervical Dystonia |
Completed |
NCT01384214 |
Phase 4 |
|
14 |
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment |
Completed |
NCT01486264 |
Phase 4 |
|
15 |
The Effect of Amantadine on Movement Disorder in Ataxia-Telangiectasia |
Completed |
NCT00950196 |
Phase 4 |
amantadine sulphate |
16 |
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR) |
Completed |
NCT00998660 |
Phase 4 |
|
17 |
Synergistic Effects of Neurotoxin and Physical Therapy |
Completed |
NCT02177617 |
Phase 4 |
Botox injection |
18 |
Pilot Study of the Efficacy of Pyridostigmine for Reversal of Post Injection Dysphonia Following Botulinum Neurotoxin Laryngeal Chemo-Denervation in Spasmodic Dysphonia |
Recruiting |
NCT05110417 |
Phase 4 |
Pyridostigmine Bromide 60 Milligrams (mg) |
19 |
Prospective, Open-label Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia |
Enrolling by invitation |
NCT05157100 |
Phase 4 |
Ingrezza Pill |
20 |
Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia |
Terminated |
NCT00432341 |
Phase 4 |
|
21 |
Bilateral Internal Pallidum Stimulation in Primary Generalized Dystonia |
Unknown status |
NCT00272246 |
Phase 2, Phase 3 |
|
22 |
Pallidal Stimulation in Patients With Idiopathic Generalised Dystonia |
Unknown status |
NCT00169403 |
Phase 3 |
|
23 |
Foot Dystonia Treatment by Botulinum Toxin Injections in Parkinson Disease : Efficiency of Injections Made in Extrinsic Muscle (Flexor Digitorum Longus Muscle) Compared to Intrinsic Muscle (Flexor Digitorum Brevis or Quadratus Plantae Muscles) |
Unknown status |
NCT00909883 |
Phase 3 |
Botulinum Toxin: Xeomin;Placebo |
24 |
IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia: a Double-blind Placebo-controlled Randomized Multicenter Study: The "SwissHandSpasm" Study |
Unknown status |
NCT03977493 |
Phase 3 |
Xeomin;Placebo - Concentrate |
25 |
A 48-Week Prospective, Double-Blinded, Randomized, Cross-over Design in Multicenter Study of 250 Unit of Dysport Versus 50 Unit of Neuronox Injection For Cervical Dystonia in Thai Patients |
Completed |
NCT03805152 |
Phase 3 |
Neuronox(R);Dysport (R) |
26 |
Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Trial With a Double-blind Parallel-group Extension Period to Investigate the Efficacy and Safety of Different Doses of IncobotulinumtoxinA (Xeomin) in the Treatment of Cervical Dystonia |
Completed |
NCT00407030 |
Phase 3 |
incobotulinumtoxinA (Xeomin) (240 Units);incobotulinumtoxinA (Xeomin) (120 Units);Placebo |
27 |
24-Week Prospective, Double-Blinded, Randomized, Cross-over Design in Multicenter Study of 50 Unit of Neubotulinum Toxin Type A (Neuronox) and 100 Unit of Neubotulinum Toxin Type A (Neuronox) Injection for Cervical Dystonia in Thai Patients |
Completed |
NCT04582929 |
Phase 3 |
Neuronox ® Injection |
28 |
Open Multicentre Study to Demonstrate the Efficacy and Safety of Botulinum Toxin A (500 Units Dysport®) in the Treatment of Heterogeneous Forms of Cervical Dystonia |
Completed |
NCT00447772 |
Phase 3 |
|
29 |
A Prospective, Randomized, Multi-center, Phase III, Double-Blind, Activi Controlled, Parallel-group Study to Evaliate the Efficacy and Safety of MEDITOXIN® Comparison With BOTOX® in Treatment of Cervical Dystonia |
Completed |
NCT03905304 |
Phase 3 |
|
30 |
A Phase 3, Open-Label, Multi-Center Trial to Evaluate the Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS) |
Completed |
NCT03617367 |
Phase 3 |
|
31 |
Prospective,Randomised, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Bilateral Globus Pallidus Internus - in Patients With Medically Refractory Primary Cervical Dystonia |
Completed |
NCT00148889 |
Phase 3 |
|
32 |
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial to Evaluate the Efficacy and Safety of a Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1) |
Completed |
NCT03608397 |
Phase 3 |
|
33 |
A Phase III Multicentre, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Dysport® for the Treatment of Cervical Dystonia |
Completed |
NCT00257660 |
Phase 3 |
Placebo |
34 |
A Phase III, Prospective, Multicenter, Open-label Extension Study to Assess the Longer Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Cervical Dystonia |
Completed |
NCT00288509 |
Phase 3 |
|
35 |
A Prospective, Randomized, Multi-center, Phase III, Double-blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Cervical Dystonia |
Completed |
NCT03232320 |
Phase 3 |
Meditoxin;Placebo |
36 |
Phase II/III Study of Deep Brain Stimulation in Patients With Dystonia |
Completed |
NCT00004421 |
Phase 2, Phase 3 |
|
37 |
A Phase III, Randomised, Double-blind and Open Label Phase, Active and Placebo Controlled Study Comparing the Short-term Efficacy of Two Formulations of Clostridium Botulinum Type A Toxin (Dysport and Dysport NG) to Placebo, and Assessing the Short and Long Term Efficacy and Safety of Dysport NG Following Repeated Treatments of Subjects With Cervical Dystonia |
Completed |
NCT01261611 |
Phase 3 |
Placebo |
38 |
Comparative Study of the Efficiency of Zonisamide in Myoclonus Dystonia: A Monocentric , Randomized in Cross Over and Double Blind Study Versus Placebo Study |
Completed |
NCT01806805 |
Phase 3 |
zonegran;placebo |
39 |
A Phase IIIb, Prospective, Multicentre, Open-Label Extension Study To Assess Long Term Safety And Effectiveness Of Dysport® Using 2 mL Dilution In Adults With Cervical Dystonia |
Completed |
NCT01753336 |
Phase 3 |
|
40 |
A Phase 3b, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia. |
Completed |
NCT01753310 |
Phase 3 |
Placebo |
41 |
Botulinum Toxin A (Onabotulinumtoxin A) for Foot Dystonia-associated Pain in Parkinson's Disease: A Randomized, Double-blind Placebo Control Study |
Recruiting |
NCT04277247 |
Phase 2, Phase 3 |
Botulinum toxin type A;Placebo |
42 |
Dexmedetomidine Effects on Microelectrode Recording in Deep Brain Stimulation |
Withdrawn |
NCT00608231 |
Phase 2, Phase 3 |
Dexmedetomidine Hydrochloride Infusion;Normal Saline |
43 |
Comparison of Clinical and Kinematic Assessment in the Determination of Botox® Injection Parameters in Cervical Dystonia Patients |
Unknown status |
NCT02662530 |
Phase 2 |
Botulinum Toxin Type A |
44 |
Phase II, Double Blind, Randomized, Placebo Controlled Trial of Dronabinol for the Treatment of Cervical Dystonia |
Unknown status |
NCT00418925 |
Phase 2 |
Dronabinol |
45 |
ASIS for Botox in Cervical Dystonia |
Unknown status |
NCT02074293 |
Phase 1, Phase 2 |
Gadolinium;Efficacy of Botox intramuscularly at Week 6;Efficacy of Botox intramuscularly at Week 12;Efficacy of Botox intramuscularly at Week 18;Efficacy of Botox intramuscularly at Week 24;Efficacy of Botox intramuscularly at Week 30;Efficacy of Botox subdermally at Week 6;Efficacy of Botox subdermally at Week 12;Efficacy of Botox subdermally at Week 18;Efficacy of Botox subdermally at Week 24;Efficacy of Botox subdermally at Week 30;Adverse Reactions of Botox intramuscularly;Adverse Reactions of Botox subdermally |
46 |
A Randomized Double Blind Study of Cannabis on Dystonia and Spasticity in Pediatric Patients |
Unknown status |
NCT02470325 |
Phase 2 |
Avidekel oil;Enriched Avidekel oil |
47 |
Multicenter, Randomized Trial on the Effects of Pallidal Deep Brain Stimulation for Tardive Dystonia |
Unknown status |
NCT00331669 |
Phase 2 |
|
48 |
Pilot Open-label and Blinded Clinical Trial of Transcranial Direct-current Stimulation in Childhood Dystonia |
Unknown status |
NCT01460771 |
Phase 2 |
|
49 |
A Pilot Dose Ranging Study of Dysport® (AbobotulinumtoxinA) in the Treatment of Oromandibular Dystonia |
Completed |
NCT01921270 |
Phase 1, Phase 2 |
Low Dose - AbobotulinumtoxinA |
50 |
Deep Brain Stimulation of the Globus Pallidus Interna or the Subthalamic Nucleus for Treatment of Generalized Primary Dystonia |
Completed |
NCT00105430 |
Phase 2 |
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Amantadine
Amantadine Hydrochloride
Botulinum Toxin Type A
|
botulinum toxin type B
rimabotulinumtoxinB
|
Cochrane evidence based reviews: dystonia
|